BioSpace News Archive

Minimum wage increased from $12.50 to $13.50 to continue to lead industry in Charlotte region

eMindful, the leading provider of purpose-driven mindfulness programs that improve health and productivity and lower healthcare costs, today announced it has appointed Seth Feuerstein, MD, JD, and Julius Mokrauer, managing director for Evolve Ventures and Evolve Foundation, to its Board of Directors.

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of high-grade cannabis extracted ingredients for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is pleased to announce the appointment of Michael Kinley CPA,CA to the position of Chief Financial Officer.

Feb. 6, 2020 18:00 UTC Hines to lead company’s expansion into clinical grade product lines FOLSOM, Calif.--( BUSINESS WIRE )-- StemExpress announced that Dr. Victoria Hines has been appointed Vice President of Clinical and will direct the company as they expand their offerings to include clinical grade products. Hines will lead global clinical operations, strategy and execution for StemExpress. The increasing demand for cell and gene therapies to treat various diseases

Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively “HDF”), the beneficial owners of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), today announced that it has filed a complaint in the U.S. District Court for the Southern District of New York asserting direct claims against Enzo and asserting both direct and derivative claims against members of its Board of Directors (the “Board”) (Case 1:20-cv-01021).

Natus Medical Incorporated announced financial results for the three months and full year ended December 31, 2019.

Ultragenyx Pharmaceutical Inc. announced that it will host a conference call on Thursday, February 13, 2020 at 5pm ET to discuss its financial results and corporate update for the fourth quarter and the year ended December 31, 2019.

miRagen Therapeutics, Inc. announced that it intends to offer for sale shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering.

Brooks Automation, Inc., a leader in automation solutions for the semiconductor manufacturing and life sciences industries, reported financial results for the first fiscal quarter of 2020, ended December 31, 2019.

Blueprint Medicines Corporation announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, February 13, 2020 to report its fourth quarter and full year 2019 financial results and provide a corporate update.